Alex Sapir

Chief Executive Officer, Dova Pharmaceuticals Inc.

Companies

Fulcrum Therapeutics (United States)Board member Jul 3, 2023 to now¹
Fulcrum Therapeutics (United States)Officer Jul 3, 2023 to now¹
PhaseBio Pharmaceuticals IncBoard member Feb 14, 2020 to May 19, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Fulcrum Therapeutics (United States) FULC193,360 shares³$709.6K at $3.67Jul 3, 2024
PhaseBio Pharmaceuticals Inc3,750 shares⁴May 19, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 3, 2024Exercised options 150,000 shares at $3.27 of Fulcrum Therapeutics (United States)³
Mar 4, 2024Bought 43,360 shares at $11.35 of Fulcrum Therapeutics (United States)⁵
May 19, 2023Exercised options 3,750 shares of PhaseBio Pharmaceuticals Inc⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFulcrum Therapeutics (United States), Board member
2
SEC EDGARPhaseBio Pharmaceuticals Inc, Board member
3
SEC EDGARFulcrum Therapeutics (United States) shares after the filing of Jul 3, 2024
4
SEC EDGARPhaseBio Pharmaceuticals Inc shares after the filing of May 19, 2023
5
SEC EDGARForm 4 filed Mar 5, 2024